Last reviewed · How we verify

NCT07095062: CONNETTOMA

Electroencephalogram in Patients With Friedreich's Ataxia for the Study of the Structural and Functional Connectome.

Recruiting now NA Last updated 31 July 2025
What this trial tests

NA trial testing HD-EEG recordings, combined with cognitive and motor assessment in Friedreich's Ataxia in 30 participants. Currently enrolling.

Timeline
7 July 2025
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorIRCCS Eugenio Medea
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment30
Start date7 July 2025
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

IRCCS Eugenio Medea — full company profile →

Who can join

Adults 8 to 60, any sex, with Friedreich's Ataxia or Motor Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, exploratory, multicenter pilot study investigating the structural and functional connectome in patients with Friedreich's Ataxia (FRDA) using high-density electroencephalogram (HD-EEG). The aim is to identify neurophysiological biomarkers and analyze the relationship between cortical connectivity, cognitive functioning, and clinical severity, particularly in response to rehabilitation treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other IRCCS Eugenio Medea trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07095062.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing